BioCentury
ARTICLE | Company News

Merck management update

December 6, 2010 8:00 AM UTC

Merck & Co. Inc. (NYSE:MRK), Whitehouse Station, N.J. Business: Pharmaceuticals Transitioning: Kenneth Frazier to CEO and a director, effective Jan. 1, while remaining president; he replaces Richard C...